drug

personalized information about lung damage

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Hospital Universitario Reina Sofia de Cordoba
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Tobacco Intensive Motivational and Estimate Risk
NCT03583203—Completed

KOLs & investigators

1
Fernando Sarramea Crespo, Phd

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Hospital Universitario Reina Sofia de Cordoba
company
trial
Tobacco Intensive Motivational and Estimate Risk
NA
trial
indication
Schizophrenia
indication
Smoking Cessation
indication
Bipolar Disorder
indication
Pulmonary Disease, Chronic Obstructive
indication
KOL
Fernando Sarramea Crespo, Phd
KOL score —
person